DM 2 update

Since publication of guidelines for type 2 diabetes a number of negative trials and cardiovascular safety issues have surfaced. A new evidence synthesis was needed, and authors of a review published in the January 1 issue of American Family Physician took a stab at it. AFP is no longer open access so I can’t link to the full article, but this Medscape CME activity provides a summary. (The CME content is non-industry supported).